Prevalence of symptomatic pelvic floor disorders in US women
- PMID: 18799443
- PMCID: PMC2918416
- DOI: 10.1001/jama.300.11.1311
Prevalence of symptomatic pelvic floor disorders in US women
Abstract
Context: Pelvic floor disorders (urinary incontinence, fecal incontinence, and pelvic organ prolapse) affect many women. No national prevalence estimates derived from the same population-based sample exists for multiple pelvic floor disorders in women in the United States.
Objective: To provide national prevalence estimates of symptomatic pelvic floor disorders in US women.
Design, setting, and participants: A cross-sectional analysis of 1961 nonpregnant women (>or=20 years) who participated in the 2005-2006 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Women were interviewed in their homes and then underwent standardized physical examinations in a mobile examination center. Urinary incontinence (score of >or=3 on a validated incontinence severity index, constituting moderate to severe leakage), fecal incontinence (at least monthly leakage of solid, liquid, or mucous stool), and pelvic organ prolapse (seeing/feeling a bulge in or outside the vagina) symptoms were assessed.
Main outcome measures: Weighted prevalence estimates of urinary incontinence, fecal incontinence, and pelvic organ prolapse symptoms.
Results: The weighted prevalence of at least 1 pelvic floor disorder was 23.7% (95% confidence interval [CI], 21.2%-26.2%), with 15.7% of women (95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women (95% CI, 7.3%-10.7%) experiencing fecal incontinence, and 2.9% of women (95% CI, 2.1%-3.7%) experiencing pelvic organ prolapse. The proportion of women reporting at least 1 disorder increased incrementally with age, ranging from 9.7% (95% CI, 7.8%-11.7%) in women between ages 20 and 39 years to 49.7% (95% CI, 40.3%-59.1%) in those aged 80 years or older (P < .001), and parity (12.8% [95% CI, 9.0%-16.6%], 18.4% [95% CI, 12.9%-23.9%], 24.6% [95% CI, 19.5%-29.8%], and 32.4% [95% CI, 27.8%-37.1%] for 0, 1, 2, and 3 or more deliveries, respectively; P < .001). Overweight and obese women were more likely to report at least 1 pelvic floor disorder than normal weight women (26.3% [95% CI, 21.7%-30.9%], 30.4% [95% CI, 25.8%-35.0%], and 15.1% [95% CI, 11.6%-18.7%], respectively; P < .001). We detected no differences in prevalence by racial/ethnic group.
Conclusion: Pelvic floor disorders affect a substantial proportion of women and increase with age.
References
-
- Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–506. - PubMed
-
- Sandvik H, Seim A, Vanvik A, Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests. Neurourol Urodyn. 2000;19(2):137–145. - PubMed
-
- Sandvik H, Espuna M, Hunskaar S. Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(5):520–524. - PubMed
-
- Rockwood TH, Church JM, Fleshman JW, et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43(1):9–16. - PubMed
-
- Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42(12):1525–1532. - PubMed
Publication types
MeSH terms
Grants and funding
- U10 HD041261/HD/NICHD NIH HHS/United States
- U01 HD041249/HD/NICHD NIH HHS/United States
- U10 HD054215/HD/NICHD NIH HHS/United States
- U10 HD054214/HD/NICHD NIH HHS/United States
- U10 HD54215/HD/NICHD NIH HHS/United States
- U10 HD41261/HD/NICHD NIH HHS/United States
- U10 HD41248/HD/NICHD NIH HHS/United States
- U10 HD41268/HD/NICHD NIH HHS/United States
- U10 HD041263/HD/NICHD NIH HHS/United States
- U10 HD041267/HD/NICHD NIH HHS/United States
- U10 HD041248/HD/NICHD NIH HHS/United States
- U10 HD041269/HD/NICHD NIH HHS/United States
- U10 HD041268/HD/NICHD NIH HHS/United States
- U10 HD041250/HD/NICHD NIH HHS/United States
- U10 HD41267/HD/NICHD NIH HHS/United States
- U10 HD41269/HD/NICHD NIH HHS/United States
- U10 HD54136/HD/NICHD NIH HHS/United States
- U10 HD41250/HD/NICHD NIH HHS/United States
- U10 HD54214/HD/NICHD NIH HHS/United States
- U10 HD41263/HD/NICHD NIH HHS/United States
- U01 HD41249/HD/NICHD NIH HHS/United States
- UG1 HD041267/HD/NICHD NIH HHS/United States
- U10 HD054136/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical